|
|
|
|
| LEADER |
01257nas a2200253 u 4500 |
| 001 |
10028132 |
| 003 |
upatras |
| 005 |
20210117195639.0 |
| 008 |
751007s1965 us m p eng |
| 952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 21676
|a LISP
|b LISP
|c SER
|d 2016-04-24
|i 915
|l 0
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y JNL
|
| 999 |
|
|
|c 13026
|d 13026
|
| 022 |
|
|
|a 0026-895X
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a 615.1
|
| 110 |
|
0 |
|a American Society for Pharmacology and Experimental Therapeutics
|9 24641
|
| 222 |
|
0 |
|a Molecular pharmacology
|b [Περιοδικό]
|
| 245 |
1 |
0 |
|a Molecular pharmacology
|h [Περιοδικό]
|
| 260 |
|
|
|a Baltimore, MD [etc.]
|b American Society for Pharmacology and Experimental Therapeutics [etc.]
|
| 310 |
|
|
|a Μηνιαίο
|
| 362 |
0 |
|
|a 19(1981) -
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b B
|k ΠΕΡ
|m 915
|t 1
|3 19(1981)-
|3 Vol.56:No.4(1999:OCT)-Vol.71:No.3(2007:MAR), Vol.71:No.5(2007:MAY)-Vol.75:No.1(2009:JAN), Vol.75:No.3(2009:MAR)-Vol.77:No.4(2010:APR), Vol.78:No.1(2010:JUL)-Vol.80:No.6(2011:DEC)
|
| 866 |
|
|
|a 19(1981)-
|a Vol.56:No.4(1999:OCT)-Vol.71:No.3(2007:MAR), Vol.71:No.5(2007:MAY)-Vol.75:No.1(2009:JAN), Vol.75:No.3(2009:MAR)-Vol.77:No.4(2010:APR), Vol.78:No.1(2010:JUL)-Vol.80:No.6(2011:DEC)
|
| 942 |
|
|
|2 ddc
|s 1
|c JNL
|
